Status:
COMPLETED
Adherence of Stalevo, Entacapone and Levodopa
Lead Sponsor:
South Glasgow University Hospitals NHS Trust
Conditions:
Parkinson's Disease
Eligibility:
All Genders
18-85 years
Brief Summary
To test if combining two antiparkinson drugs into a single tablet improves accuracy of medicine intake by the patient. To test if patients with Parkinson's disease who take medicines at regular time ...
Eligibility Criteria
Inclusion
- Patients diagnosed with Parkinson's disease aged between 18 and 85 years fulfilling UK Brain Bank criteria.
- Current levodopa therapy prescribed on a regular basis three or more times per day but requiring entacapone because of 'wearing off'
- Able to manipulate electronic monitoring bottles and complete questionnaires
Exclusion
- Current use of compliance aid such that study participation would be detrimental to patient's adherence
- Pregnancy or breast feeding
- Excess alcohol (over 21 units per week for women and 28 units for men)
- Mini mental state examination of less than 26.
- Severe depression (Geriatric depression score over 20)
Key Trial Info
Start Date :
April 1 2005
Trial Type :
OBSERVATIONAL
End Date :
July 1 2006
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00245700
Start Date
April 1 2005
End Date
July 1 2006
Last Update
May 23 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southern General Hospital
Glasgow, Scotland, United Kingdom, G51 4TF